Can China’s HelixFold 3 Rival DeepMind’s AlphaFold 3? A Deep Dive

Background

AlphaFold 2, released in December 2020, demonstrated that deep‑learning can predict protein three‑dimensional structures within hours, dramatically accelerating biomedical research compared with traditional experimental methods.

AlphaFold 3 breakthrough

In May 2024 DeepMind launched AlphaFold 3, extending prediction capabilities to multiple biomolecule types—including proteins, small‑molecule ligands, DNA, RNA and ions—and reducing modeling time from years to a few minutes while achieving experimental‑level accuracy.

HelixFold 3 – China’s answer

In August 2024 Baidu’s HelixFold 3 was publicly released. It reproduces AlphaFold 3’s performance on protein‑ligand, nucleic‑acid and protein‑protein interaction predictions, making it the world’s first domestic model explicitly benchmarked against AlphaFold 3.

Performance comparison

Extensive testing shows HelixFold 3’s accuracy matches AlphaFold 3 on the PoseBusters small‑molecule ligand benchmark, on RNA/DNA datasets from CASP15 and PDB, and on protein‑protein complex prediction, often surpassing other state‑of‑the‑art methods such as RoseTTAFold2NA and AlphaFold‑Multimer.

“AlphaFold 3 was released less than three months ago, yet a domestic model can already replicate its results; HelixFold 3’s prediction accuracy for protein‑ligand interactions is surprisingly high.” – R&D leader, pharmaceutical industry

Cloud service and API

HelixFold 3 is offered through Baidu Cloud’s High‑Performance Computing (CHPC) platform, allowing researchers to run large‑scale predictions with a few clicks and to integrate batch‑submission APIs into their own pipelines for drug discovery, peptide design, mRNA development and other life‑science applications.

Confidence scoring

The model outputs confidence scores for each prediction. Across PoseBusters, RNA/DNA, and protein‑protein datasets, these scores correlate strongly with structural accuracy, providing a reliable metric for downstream analysis.